JCO at ASCO 2026: Individual Patient Pooled Analysis of Low-Dose Tamoxifen in DCIS

JCO at ASCO 2026: Individual Patient Pooled Analysis of Low-Dose Tamoxifen in DCIS

Author: American Society of Clinical Oncology (ASCO) May 31, 2026 Duration: 11:19

JCO Editorial Fellow Dr. Yuvanesh Vedaraju and JCO Associate Editor Dr. Kathy Miller discuss the ASCO 2026 Simultaneous Publication paper "Low-Dose Tamoxifen in Non-Invasive Breast Neoplasia: Long-Term Results from an Individual Participant Data Pooled Analysis."

LINK TO FULL TRANSCRIPT

 


Hosted by Dr. Davide Soldato, the Journal of Clinical Oncology (JCO) Podcast from the American Society of Clinical Oncology (ASCO) transforms pivotal research into accessible conversation. Each episode focuses directly on a significant study or theme from the latest issue of the Journal of Clinical Oncology, moving from the printed page into a dynamic analysis of what the findings truly mean. Listeners are brought into a detailed scholarly discourse that unpacks methodology, contextualizes results, and debates implications for real-world patient care. This isn't just a summary; it's a critical examination designed for practicing oncologists, fellows, and dedicated healthcare professionals who need to integrate cutting-edge evidence into their daily decisions. The podcast regularly features interviews and in-depth summaries led by the journal's annual fellows, adding fresh, trainee-led perspectives on complex oncology topics. By focusing on the most urgent and practice-changing publications, this podcast serves as an essential audio companion for anyone committed to understanding the rapid evolution of cancer treatment. It’s where rigorous science meets clinical reality, helping the oncology community navigate a constant stream of advancements through informed discussion and expert insight.
Author: Language: English Episodes: 50

Journal of Clinical Oncology (JCO) Podcast
Podcast Episodes
Pembrolizumab and Bevacizumab for Melanoma Brain Metastases [not-audio_url] [/not-audio_url]

Duration: 23:59
Host Dr. Davide Soldato and guest Dr. Harriet Kluger discuss the JCO article "Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases." Transcript The guest on this podcast…
JCO Article Insights: Smoking Assessment [not-audio_url] [/not-audio_url]

Duration: 8:35
In this JCO Article Insights episode, Lauren Shih summaries "Longitudinal Results From the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons–Accredited Cancer Programs"…
Botensilimab Plus Balstilimab in Advanced Sarcomas [not-audio_url] [/not-audio_url]

Duration: 21:00
Dr. Shannon Westin and her guest, Dr. Breelyn Wilky, discuss the JCO article, ""Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With R…
High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer [not-audio_url] [/not-audio_url]

Duration: 12:12
Host Dr. Shannon Westin and guests Dr. Bill Aronson discuss the article "High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial" and how…
JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC [not-audio_url] [/not-audio_url]

Duration: 10:21
In this JCO Article Insights episode, Ece Cali summarizes findings from the JCO article, "Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized,…
Air Pollution and Breast Cancer Incidence [not-audio_url] [/not-audio_url]

Duration: 25:43
Host Dr. Davide Soldato and his guests Dr. Ann Wu and Dr. Alexa White discuss the article "Air Pollution and Breast Cancer Incidence in the Multiethnic Cohort Study" and the editorial "Growing Evidence for the Role of Ai…